Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: A multicenter, randomized study
Authors:
- 1 February 2009
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 22 (1) , 44-49
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Global burden of COPD: systematic review and meta-analysisEuropean Respiratory Journal, 2006
- Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary diseaseRespiratory Medicine, 2005
- Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV1 reversibilityCurrent Medical Research and Opinion, 2004
- Effects of Formoterol Inhaled Dry Powder on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover StudyCurrent Therapeutic Research, 2003
- Onset of Action of Single Doses of Formoterol Administered via Turbuhaler in Patients with Stable COPDPulmonary Pharmacology & Therapeutics, 2001
- Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPDEuropean Respiratory Journal, 1998
- Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actionEuropean Respiratory Journal, 1996
- Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response studyRespiratory Medicine, 1995
- Effect of Salmeterol and Formoterol in Patients with Chronic Obstructive Pulmonary DiseasePulmonary Pharmacology, 1994